标题
Translatability scoring in drug development: eight case studies
作者
关键词
-
出版物
Journal of Translational Medicine
Volume 10, Issue 1, Pages 39
出版商
Springer Nature
发表日期
2012-03-08
DOI
10.1186/1479-5876-10-39
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Drug development in the light of translational science: shine or shade?
- (2011) Martin Wehling DRUG DISCOVERY TODAY
- Alzheimer's disease
- (2011) Clive Ballard et al. LANCET
- APP processing in Alzheimer's disease
- (2011) Yun-wu Zhang et al. Molecular Brain
- Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
- (2010) S. J. O'Day et al. ANNALS OF ONCOLOGY
- The translatability of animal models for clinical development: biomarkers and disease models
- (2010) Alexandra Wendler et al. CURRENT OPINION IN PHARMACOLOGY
- Current Therapeutic Strategies and Future Perspectives for the Prevention of Arterial Thromboembolism: Focus on Atrial Fibrillation
- (2010) Tatjana S. Potpara et al. CURRENT PHARMACEUTICAL DESIGN
- Dramatic responses to gefitinib when used as front line therapy in two cases of metastatic lung adenocarcinoma with poor performance status
- (2010) Ajay Gupta et al. Journal of Cancer Research and Therapeutics
- Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic T-lymphocyte antigen-4 blockade in advanced melanoma
- (2010) Sanjiv S. Agarwala MELANOMA RESEARCH
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Strategies for Alzheimer Disease and Cognitive Impairment
- (2010) Kenneth Maiese et al. Oxidative Medicine and Cellular Longevity
- The Puzzling Rise and Fall of a Dark-Horse Alzheimer's Drug
- (2010) G. Miller SCIENCE
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma
- (2009) J. Weber et al. CLINICAL CANCER RESEARCH
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Vilazodone: A 5-HT1AReceptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders
- (2009) Lee A. Dawson et al. CNS Neuroscience & Therapeutics
- Animal models for atrial fibrillation: clinical insights and scientific opportunities
- (2009) K. Nishida et al. EUROPACE
- Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression
- (2009) Arif Khan EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Current systemic therapy for metastatic melanoma
- (2009) Sanjiv S Agarwala Expert Review of Anticancer Therapy
- Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder
- (2009) Karl Rickels et al. JOURNAL OF CLINICAL PSYCHIATRY
- Assessment of mood: Guides for clinicians
- (2009) Toshi A. Furukawa JOURNAL OF PSYCHOSOMATIC RESEARCH
- Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
- (2009) Jedd D Wolchok et al. LANCET ONCOLOGY
- Assessing the translatability of drug projects: what needs to be scored to predict success?
- (2009) Martin Wehling NATURE REVIEWS DRUG DISCOVERY
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer Disease
- (2008) Adam S. Fleisher et al. ARCHIVES OF NEUROLOGY
- Information Learned from Animal Models of Atrial Fibrillation
- (2008) J. Emanuel Finet et al. CARDIOLOGY CLINICS
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
- (2008) Rachelle S Doody et al. LANCET
- Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
- (2008) Edward S Kim et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now